Register | Log in

the chairmans blog

Ron Najafi, Ph.D.

 

Ramin (“Ron”) Najafi is the founder and Chairman of NovaBay. He has served as President since July 2002, and as Chief Executive Officer since November 2004.
(read full bio)

Official NovaBay Pharmaceuticals, Inc. social media
 

Terms of use: NovaBay Pharmaceuticals, Inc.

Ron Najafi, Ph.D. on the Chairmans Blog

LEGAL NOTICE

This page provides the terms and conditions under which you may use this web site (“Terms and Conditions”). NovaBay Pharmaceuticals, Inc. ("NovaBay") may update this posting and may modify the Terms and Conditions at any time at its discretion. YOU MUST READ AND REVIEW THIS PAGE PERIODICALLY BECAUSE YOUR USE OF THIS WEB SITE IS SUBJECT TO AND GOVERNED BY THE TERMS AND CONDITIONS SET FORTH HEREIN. YOUR USAGE OF THE WEB SITE SHALL CONSTITUTE YOUR ACCEPTANCE OF THESE TERMS AND CONDITIONS. YOUR CONTINUED USAGE FOLLOWING MODIFICATIONS OF THE TERMS AND CONDITIONS SHALL CONSTITUTE YOUR ACCEPTANCE OF SUCH MODIFIED TERMS AND CONDITIONS.

Forward-Looking Statements

This web site contains forward-looking statements, which reflect NovaBay’s current expectations and are based on the information available to it at this time. These forward-looking statements may include, but may not be limited to, statements regarding anticipated scientific progress on and expenses of NovaBay’s research programs, development of product candidates, interpretation of clinical results, prospects for regulatory approval, manufacturing development and capabilities, market prospects for product candidates, and other statements regarding matters that are not historical facts. The forward-looking statements involve risks and uncertainties. NovaBay can give no assurance with regard to these statements. Actual events, results or performance could differ materially from any future events, results or performance expressed or implied by statements on this web site, and depend on a number of factors, including successful and timely completion of clinical studies, uncertainties related to the regulatory process and commercialization of products thereafter. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, NovaBay® assumes no obligation to update these forward-looking statements.

Not Investment Information

The content that is made available to you on this web site is for information purposes only and is not intended to constitute an offering of securities in any jurisdiction. Information disclosed under the corporate and securities laws of those United States and Canadian jurisdictions applicable to NovaBay is not intended to be in any way qualified, amended, modified or supplemented by the information otherwise available in, through or on this web site.

Intellectual Property Notice

Copyright© 2007 NovaBay Pharmaceuticals, Inc. All rights reserved.

NovaBay either owns the intellectual property rights in the underlying HTML, text, audio clips, video clips and other content that is made available to you on this web site, or has the right to use such content. All such content is protected by copyright, patent, trademark and other intellectual property laws of the U.S., Canada, and/or foreign jurisdictions. Except as expressly allowed by these Terms and Conditions, all rights are reserved by NovaBay . Unauthorized use of the content may violate applicable copyright, trademark or other intellectual property laws or other laws.

License Grant

Subject to the Terms and Conditions set forth herein, NovaBay grants to you a limited, non-transferable, non-exclusive license to print, download and use materials and information on this web site only for non-commercial, personal purposes. Except as expressly allowed by these Terms and Conditions, nothing contained in this Section shall be construed as conferring any right in any copyright, trademark or other intellectual property of NovaBay or any other person who owns the copyright or other intellectual property in the content provided on this web site. You agree not to copy, modify, adapt, frame, mirror, reproduce, translate, distribute, transmit, reverse engineer, decompile, or disassemble any aspect of the web site and materials and information contained therein without the express consent of NovaBay .

No Warranties

Medical information that appears on this web site is for informational purposes only and is not, nor is intended to be, a medical diagnosis or a replacement for advice given by a physician or other medical professional. Reliance on any materials and information, including but not limited to such medical information, provided on this web site (“Content”) is solely the responsibility of the individual. While NovaBay makes commercially reasonable efforts to ensure the timeliness and accuracy of the Content present on this web site, NovaBay does not warrant the timeliness, accuracy, quality, or completeness of any Content on this web site. Further, NovaBay makes no representations about the suitability of any Content on this web site for any purpose. All Content is provided "as is" without express or implied warranty or condition of any kind. This web site may include inaccuracies or typographical errors.


Limitation of Liability

In no event shall NovaBay or any third party mentioned at this web site be liable to you for any damages whatsoever, including direct, special, indirect or consequential damages or loss (including but not limited to loss of profits and data), arising out of or in connection with the use of this web site and any reliance on the information and materials available on this web site, even if NovaBay or any such third party has been advised of the possibility of such damage or loss.

Links to Other Sites

This web site may contain links to other web sites which are provided solely as a convenience to you and not as an endorsement by NovaBay of the contents of such other web sites. NovaBay shall not be responsible for the content of any other web sites and does not make any representations or warranties regarding any other web sites or the contents or materials on such web sites. If you decide to access other web sites, you do so at your own risk.

Miscellaneous

This web site is controlled and operated by NovaBay from its offices in the state of California in the United States. These Terms and Conditions are governed by and to be construed in accordance with the laws of the State of California without regard to its conflict of law provisions.

NovaBay and the NovaBay logo are trademarks of NovaBay Pharmaceuticals, Inc. Any use of such marks without the express written permission of NovaBay® is strictly prohibited

NovaBay Pharmaceuticals, Inc. (NBY) Stock info

Cautionary Information Regarding Forward-Looking Statements This release contains forward-looking statements, which are based upon NovaBay's current expectations, assumptions, estimates, projections and beliefs. Many of these statements are identified by the use of words denoting future events, such as "expect," "anticipate," "plan," "intend," "will," "estimated" and variations of such words. These forward-looking statements include, but not limited to, NovaBay's plans and expectations regarding ongoing and future clinical trials, the timing of commencement and receiving results of clinical trials, the potential achievement of multiple clinical and business development milestones, the plan to build its own commercial organization with respect to Urology, and potential future partnerships in urology and hospital products. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. Factors that might cause to such differences include, but are not limited to: the risk that negative results from development programs could preclude Galderma from providing additional funding to NovaBay; the risk of unexpected delays in the regulatory process may delay the commencement or completion of clinical trials; inherent risks and uncertainties relating to difficulties or delays in conducting clinical trials; the inherent uncertainty of patent protection for the company's intellectual property or trade secrets; the risks that results obtained in animal models may not be obtained in humans; as well other as risks relating to NovaBay and its Aganocide compounds detailed in NovaBay's Quarterly Report on Form 10-Q, under the caption "Risk Factors" in Item 1A of Part II of that report, which was filed with the Securities and Exchange Commission on November 7, 2011. The forward-looking statements in this release speak only as of this date, and NovaBay disclaims any intent or obligation to revise or update publicly any forward-looking statement except as required by law.
This Blog is official and sanctioned by NovaBay Pharmaceuticals, Inc. | See Terms of use »


(No commercial advertising involvement of any kind has been solicited or accepted in the authorship of the content within a Chairman's company blog.
Advertising placed on this website is not endorsed or affiliated with authors, the chairmen, CEO's, or their respective companies.)